The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
{(R)-6-[(Diphenylcarbamoyloxy)-methyl]-6-hydroxy-5,6,7,8-tetrahydro-naphthalen-1-yloxy}-acetic acid ID: ALA196779
Cas Number: 227951-89-5
PubChem CID: 9911469
Product Number: F610330, Order Now?
Max Phase: Preclinical
Molecular Formula: C26H25NO6
Molecular Weight: 447.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: FK-788 | FK-788|227951-89-5|UNII-LSJ4493RPW|LSJ4493RPW|FK 788|CHEMBL196779|GTPL5855|SCHEMBL6612986|DTXSID70945479|FK788|BDBM50167887|SB19698|A857154|Q27077300|(R)-2-(6-((diphenylcarbamoyloxy)methyl)-6-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yloxy)acetic acid|[(6-{[(Diphenylcarbamoyl)oxy]methyl}-6-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)oxy]acetic acid|{(R)-6-[(Diphenylcarbamoyloxy)-methyl]-6-hydroxy-5,6,7,8-tetrahydro-naphthalen-1-yloxy}-acetic acid|2-[[(6R)-6-(diphenylcarbamoyloxymethyl)-6-hyd Show More⌵
Canonical SMILES: O=C(O)COc1cccc2c1CC[C@](O)(COC(=O)N(c1ccccc1)c1ccccc1)C2
Standard InChI: InChI=1S/C26H25NO6/c28-24(29)17-32-23-13-7-8-19-16-26(31,15-14-22(19)23)18-33-25(30)27(20-9-3-1-4-10-20)21-11-5-2-6-12-21/h1-13,31H,14-18H2,(H,28,29)/t26-/m1/s1
Standard InChI Key: UZJAIYJXBYWENR-AREMUKBSSA-N
Molfile:
RDKit 2D
33 36 0 0 1 0 0 0 0 0999 V2000
6.3917 1.8583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1042 1.4500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8250 0.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8250 1.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6792 1.4458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5417 0.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2500 1.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3917 -1.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5292 1.8458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1042 0.1833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3875 2.6833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1042 -0.6417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1125 0.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8167 1.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1042 -2.2917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2542 0.6083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9625 1.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3917 -1.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6792 -2.2917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2417 2.2583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1042 1.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3917 1.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3917 0.5958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5292 1.4583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8125 2.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4000 0.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8250 0.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5167 3.1083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4042 -0.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8292 -0.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2417 1.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1167 -1.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2417 2.7083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 6 1 0
4 9 1 0
5 1 1 0
6 16 1 0
7 17 1 0
8 18 1 0
9 7 1 0
10 3 2 0
11 1 2 0
12 10 1 0
13 2 1 0
14 2 1 0
15 8 2 0
16 7 1 0
17 5 1 0
18 12 1 0
19 8 1 0
7 20 1 6
21 4 2 0
22 21 1 0
23 10 1 0
24 14 2 0
25 14 1 0
26 13 2 0
27 13 1 0
28 25 2 0
29 26 1 0
30 27 2 0
31 24 1 0
32 30 1 0
33 28 1 0
4 3 1 0
31 33 2 0
29 32 2 0
22 23 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 447.49Molecular Weight (Monoisotopic): 447.1682AlogP: 4.34#Rotatable Bonds: 7Polar Surface Area: 96.30Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.68CX Basic pKa: ┄CX LogP: 4.46CX LogD: 1.15Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -0.01
References 1. Hattori K, Tanaka A, Okitsu O, Tabuchi S, Taniguchi K, Nishio M, Koyama S, Higaki M, Seki J, Sakane K.. (2005) Discovery of diphenylcarbamate derivatives as highly potent and selective IP receptor agonists: orally active prostacyclin mimetics. Part 3., 15 (12): [PMID:15914004 ] [10.1016/j.bmcl.2005.04.047 ] 2. Takamura F, Tanaka A, Takasugi H, Taniguchi K, Nishio M, Seki J, Hattori K.. (2006) Metabolism investigation leading to novel drug design 2: orally active prostacyclin mimetics. Part 5., 16 (17): [PMID:16824754 ] [10.1016/j.bmcl.2006.06.033 ] 3. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of MMV (CH) - Pandemic Response Box, [10.6019/CHEMBL4513161 ]